Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A hereditary disorder that leads to a selective defect in renal or intestinal magnesium absorption, resulting in a low serum magnesium concentration.
Biomarker and diagnostic research for familial primary hypomagnesemia has been reported in the published literature.
1 clinical trial registered, 1 recruiting. Interventions under study include other interventions. Research is primarily sponsored by academic and government institutions.
106 publications have been identified in PubMed for familial primary hypomagnesemia. Research spans Review / Meta-Analysis (40%), Epidemiology / Natural History (27%), and Clinical Trial Publication (13%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 42 | 40% |
Data assembled from 4 of 12 sources · Last updated Sep 20, 2026, 3:02 PM UTC
European rare disease database
Disease patterns and progression |
29 |
27% |
Clinical study results | 14 | 13% |
Patient case studies | 7 | 7% |
Laboratory research | 7 | 7% |
New treatment approaches | 4 | 4% |
Testing and diagnosis research | 2 | 2% |
Other research | 1 | 1% |
Nakata K (2026). [PMID: 41452545](https://pubmed.ncbi.nlm.nih.gov/41452545/). *Clin Exp Nephrol*. [Epidemiology / Natural History]
Sakihara T (2026). [PMID: 41656096](https://pubmed.ncbi.nlm.nih.gov/41656096/). *Cell Struct Funct*. [Clinical Trial Publication]
Maheshwary A (2026). [PMID: 30285361](https://pubmed.ncbi.nlm.nih.gov/30285361/). *Unknown Journal*. [Epidemiology / Natural History]
Llewellyn E (2026). [PMID: 40998669](https://pubmed.ncbi.nlm.nih.gov/40998669/). *Vet Clin North Am Small Anim Pract*. [Review / Meta-Analysis]
Papagiannidou A (2026). [PMID: 41872423](https://pubmed.ncbi.nlm.nih.gov/41872423/). *Curr Nutr Rep*. [Review / Meta-Analysis]
Güzel HG (2026). [PMID: 41930183](https://pubmed.ncbi.nlm.nih.gov/41930183/). *Cancer Manag Res*. [Diagnostic / Biomarker]
Yin Y (2026). [PMID: 41338273](https://pubmed.ncbi.nlm.nih.gov/41338273/). *Eur Heart J*. [Clinical Trial Publication]
González-Río E (2026). [PMID: 42174218](https://pubmed.ncbi.nlm.nih.gov/42174218/). *Pediatr Nephrol*. [Epidemiology / Natural History]
Aotani R (2026). [PMID: 41668966](https://pubmed.ncbi.nlm.nih.gov/41668966/). *JCEM Case Rep*. [Case Report / Case Series]
Wynne Z (2026). [PMID: 41656031](https://pubmed.ncbi.nlm.nih.gov/41656031/). *Endocrinol Metab Clin North Am*. [Review / Meta-Analysis]
AI-curated news mentioning familial primary hypomagnesemia
Updated Jun 15, 2026
A recent study explores the link between early-onset calcium pyrophosphate disease and genetic hypomagnesemia, expanding the understanding beyond Gitelman syndrome. This research highlights the genetic factors contributing to these conditions.
A recent study shows that dapagliflozin effectively corrects hypomagnesemia in kidney transplant patients. This finding could influence treatment protocols for managing magnesium levels post-transplant.